Mile Marker Recognized As A Winner Of Modern Healthcare And Ad Age’s 2025 Healthcare Marketing Impact Awards
NEW YORK, Nov. 13, 2025 /PRNewswire/ -- Mile Marker has been selected by Modern Healthcare and Ad Age as a...
Pharmaceutical
Suno Software Accelerates AI Innovation to Transform Hearing Clinic Operations
The fastest-growing practice-management platform for hearing clinics, Suno Software is leveraging new funding to accelerate its AI product roadmap -...
NVNA and Hospice Rebrands as Croí Health
The nonprofit is changing its name to better represent their growth as they continue to expand access to patient-centered care...
Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at NASPGHAN Annual Meeting
Crofelemer can potentially extend and save lives of microvillus inclusion disease patients, reducing the volume of the total parenteral support...
Entero’s Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy
Timed with a sharp acceleration in AI-data-center expansion, with more than $60B in new projects announced in the last 90...
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and...
Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)
The study demonstrated that personalizing the stimulation parameters to each user dramatically enhanced autonomic effects FREMONT, CA / ACCESS Newswire...
Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study
NEW YORK CITY, NY / ACCESS Newswire / November 13, 2025 / Protagenic Therapeutics Inc. (NASDAQ:PTIX), a biopharmaceutical company developing...
Curiteva Proudly Announces the Publication of a Peer-Reviewed Study in the Journal of Biomaterials (JBI)
HUNTSVILLE, ALABAMA / ACCESS Newswire / November 13, 2025 / Curiteva, Inc. a privately held manufacturing and technology company, proudly...
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A...
Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
Vancouver, Canada, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
Strategic transaction supports the advancement of Decoy’s rapid computational design and manufacturing of innovative peptide conjugate therapeutics through its IMP3ACT™...
Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented
Completion of treatment for the first 45 patients on pace for Q1 2026 with initial unblinded data thereafter; blinded response...
Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819,...
AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes
- Combined transactions will strengthen balance sheet and reduce outstanding debt by more than 90% - - $6 million PIPE financing...
Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference
BOSTON, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company...
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040
Once issued, this new U.S. patent covers the use of CardiolRx™ and CRD-38 for a broad range of cardiac disorders,...
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040
Once issued, this new U.S. patent covers the use of CardiolRx™ and CRD-38 for a broad range of cardiac disorders,...
Clarivate Companies to Watch Report Spotlights Seven Women’s Health Startups Shaping the Future of Care
Report highlights emerging biotech innovators advancing new therapies, equity and investment across reproductive, chronic and mental health LONDON, Nov. 13,...
PeptiSystems secures growth equity investment from Rubicon Healthcare Partners to accelerate commercial expansion
UPPSALA, Sweden, Nov. 13, 2025 /PRNewswire/ -- PeptiSystems, a life science company developing advanced manufacturing solutions for peptide and oligonucleotide-based...